Treatment of Skin Oncological Disease Using an Immunosuppressive Medication
Título del documento: Treatment of Skin Oncological Disease Using an Immunosuppressive Medication
Revista: Gaceta médica de Caracas
Base de datos:
Número de sistema: 000595957
ISSN: 2739-0012
Autores: 1
2
3
2
4
5
6
Instituciones: 1Clinic for Dermatology and Sexually Transmitted Diseases. Riga 1st Hospital. LV 1001, 5 Bruninieku Str., Riga, Latvia, Department of Dermatovenereology. Riga Stradins University. LV-1007, 16 Dzirciema Str., Riga, Latvia,
2Clinic for Dermatology and Sexually Transmitted Diseases. Riga 1st Hospital. LV 1001, 5 Bruninieku Str., Riga, Latvia. Department of Dermatovenereology. Riga Stradins University. LV-1007, 16 Dzirciema Str., Riga, Latvia,
3Department of Pathology. Central Laboratory. LV 1001, 3 Sarlotes Str., Riga, Latvia,
4Department of Dermatology and Allergology. Kantonsspital St. Gallen. 9007, 95 Rorschacher Str., St. Gallen, Switzerland,
5Clinic for Dermatology and Sexually Transmitted Diseases. Riga 1st Hospital. LV 1001, 5 Bruninieku Str., Riga, Latvia Department of Doctoral Studies. Riga Stradins University. LV-1007, 16 Dzirciema Str., Riga, Latvia,
6Association of Health Centre Care. LV 1002, 12 Kokles Str., Riga, Latvia,
Año:
Volumen: 131
Número: 4
País: Venezuela
Idioma: Español
Resumen en español Skin cancer or non-melanoma malignant formations, as well as melanomas, are recorded in more than 2-3 million people every year. The most important cause of the occurrence of this disease is the effect of UV radiation on damaged areas of the skin, birthmarks, or sensitive skin (light, capable of burning). Dermatoscopy is one of the most important methods for determining the stage of tumor development, and the simplest method of treatment in the initial stages is the use of immunosuppressive agents that reduce the work of the immune system by preventing the formation of antibodies.
Palabras clave: Pharmacokinetics,
Kaposis sarcoma,
corticosteroids,
lysine cell syndrome,
dermatosis,
adenocarcinoma
Texto completo: Texto completo (Ver PDF) Texto completo (Ver HTML)